Richard Bernstein Advisors LLC Amgen Inc Transaction History

Richard Bernstein Advisors LLC

$4.64 Billion
Q3 2024

A detailed history of Richard Bernstein Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Richard Bernstein Advisors LLC holds 13,864 shares of AMGN stock, worth $3.88 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

13,864

Previous 13,864 -0.0%

Holding current value

$3.88 Million

Previous $4.33 Million 3.14%

% of portfolio

0.1%

Previous 0.1%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	BUY	$262.75 - $319.31 $525 - $638	2 Added 0.01%	13,864 $4.33 Million
Q1 2024 May 09, 2024	BUY	$268.87 - $324.56 $2,419 - $2,921	9 Added 0.06%	13,862 $3.94 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $1.41 Million - $1.79 Million	-6,143 Reduced 30.72%	13,853 $3.64 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $892,228 - $1.01 Million	-3,975 Reduced 16.58%	19,996 $4.51 Million
Q3 2021 Nov 09, 2021	BUY	$212.27 - $248.7 $206,114 - $241,487	971 Added 4.22%	23,971 $5.1 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $818,182 - $953,458	-3,687 Reduced 13.82%	23,000 $5.72 Million
Q1 2020 May 13, 2020	SELL	$182.24 - $241.7 $2.16 Million - $2.87 Million	-11,864 Reduced 30.77%	26,687 $5.41 Million
Q1 2019 May 13, 2019	BUY	$180.87 - $203.88 $2.03 Million - $2.29 Million	11,236 Added 41.13%	38,551 $7.32 Million
Q3 2018 Nov 13, 2018	BUY	$185.29 - $208.89 $5.06 Million - $5.71 Million	27,315 New	27,315 $5.66 Million

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Richard Bernstein Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Richard Bernstein Advisors LLC with notifications on news.

Account

Richard Bernstein Advisors LLC Amgen Inc Transaction History